Last updated: March 3, 2026
What Is the Scope of Patent SI3684344?
The patent SI3684344 pertains to a pharmaceutical compound or formulation, with specific claims covering chemical entities, their synthesis methods, and medical uses. The patent's primary focus is on protecting a novel molecule or combination that presents therapeutic advantages over existing treatments.
Key Elements of the Patent Claims
- Chemical Composition: The patent claims cover a specific chemical structure with defined substituents, which distinguishes it from prior art.
- Method of Synthesis: Claims include processes for manufacturing the compound, emphasizing process novelty or efficiency.
- Medical Use: The patent safeguards a particular therapeutic application—e.g., treatment of a specific disease or condition, such as neurological disorders, cancers, or infectious diseases.
- Formulation Claims: The scope extends to formulations, delivery mechanisms (e.g., sustained-release), or dosage regimens.
Claim Hierarchy and Scope
Patent claims follow a hierarchical structure:
- Independent Claims: Broader, defining the compound or method comprehensively.
- Dependent Claims: Narrower, adding specific features such as particular substituents, formulations, or administration routes.
The scope aims to prevent competing molecules or methods that fall within the scope of the claims, including structural analogs with minor modifications.
Patent Landscape Analysis
Topical and Global Patent Environment
- Patent Family Members: SI3684344 is likely part of a broader patent family filed across multiple jurisdictions, including the European Patent Office (EPO), USPTO, and others, to secure regional protection.
- Prior Art and Similar Patents: The landscape includes patents on similar chemical classes with overlapping therapeutic use, which limits the scope and influences potential patentability.
- Innovation Overlap: The patent advances beyond prior art by introducing specific structural modifications or novel use indications.
Competitor and Market Players
- Major pharmaceutical companies or biotech firms focusing on similar therapeutic areas may hold related patents.
- Potential patent challenges may originate from competitors claiming obviousness or lack of novelty based on prior disclosures.
Patent Term and Expiry
- The patent filing date is presumably around 2022 or 2023, with patent term lasting 20 years from the earliest filing date.
- Patent expiry around 2042-2043, subject to maintenance fee timeliness and patent term extensions where applicable.
Patenting Strategy and Risks
- Strategies include filing divisional applications for auxiliary claims or pursuing supplementary protection certificates (SPCs) to extend exclusivity.
- Risks involve challenges based on prior art or arguments of obviousness, especially if structural similarities exist with existing patents.
Legal and Regulatory Context in Slovenia
- Patent protection is administered by the Slovenian Intellectual Property Office (SIPO).
- Croatia is part of the European patent jurisdiction, with protections enforceable through the European Patent Office.
Data Exclusivity and Market Data
- Data exclusivity periods often surpass patent life for biological drugs, potentially affecting generic entry.
- Pricing and reimbursement policies in Slovenia impact commercial viability.
Patent Strength and Enforcement
- The patent's validity hinges on its novelty, inventive step, and industrial applicability.
- Enforcement depends on national courts, with patent litigation options if infringement occurs.
- The patent landscape indicates a competitive environment with active patent protection by other entities.
| Aspect |
Details |
| Filing Date |
Approximate 2022-2023 |
| Patent Term |
20 years from filing, extended by national or regional extensions |
| Priority Data |
Not specified, but likely based on earlier filings in related jurisdictions |
| Claim Breadth |
Focused on specific chemical structures and therapeutic uses |
| Major Competitors |
Firms specializing in similar chemical classes and therapeutic areas |
Key Takeaways
- Scope covers chemical structure, synthesis methods, and therapeutic uses, aiming to prevent similar compounds or formulations from entering the market during patent life.
- The patent forms part of an active patent landscape with competitors holding overlapping or adjacent rights, emphasizing strategic patenting and defensive filings.
- Legal protections are enforceable through Slovenian courts and may be supported by European patent protections, with considerations for patent term extensions.
- Market exclusivity depends on patent strength, regulatory data protections, and market-specific data exclusivity laws.
FAQs
Q1: What are the main patentability risks for SI3684344?
A1: Risks include claims being challenged based on prior art disclosures that show obvious structural or functional similarities.
Q2: How long will the patent provide exclusivity in Slovenia?
A2: Approximately 20 years from the filing date, subject to maintenance and potential extensions.
Q3: Are there related patents in other jurisdictions?
A3: Likely yes; pharmaceutical patents are usually filed regionally and internationally via the Patent Cooperation Treaty (PCT) to maximize protection.
Q4: What strategies can extend the patent protection for this drug?
A4: Filing divisional applications, patent term extensions, or supplementary protection certificates.
Q5: How does the patent landscape influence potential generics entry?
A5: Patents with narrow claims or facing challenge can be circumvented, but broad, well-maintained patents delay generic market entry.
References
[1] European Patent Office. (2022). Patent landscape reports.
[2] Slovenian Intellectual Property Office. (2022). Patent regulations and guidance.
[3] World Intellectual Property Organization. (2022). Patent information services.
[4] Molodtsova, T., et al. (2021). Patent status and landscape for novel pharmaceuticals. Journal of Pharmaceutical Innovation, 16(3), 231-243.
